"Cleveland Clinic is one of the largest and most respected hospitals in the country. Our mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. Learn more about our leadership, vision, values and model of healthcare. Every life deserves world class care. Call or visit our website for appointment information."

During the past decade, Cleveland Clinic Foundation; Cole Eye Institute conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 17 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 13 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Foundation; Cole Eye Institute" #1 sponsor was "The Cleveland Clinic" with 12 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Apellis Pharmaceuticals, Inc." with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored and "Kodiak Sciences Inc" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Foundation; Cole Eye Institute" #1 collaborator was "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "National Eye Institute (NEI)" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Foundation; Cole Eye Institute" are "Diabetic Macular Edema" (8 trials), "Geographic Atrophy" (8 trials), "Macular Edema" (4 trials), "Diabetic Retinopathy" (3 trials) and "Epiretinal Membrane" (3 trials). Many other conditions were trialed in "Cleveland Clinic Foundation; Cole Eye Institute" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Foundation; Cole Eye Institute" are "Drug" (39 trials), "Other" (12 trials), "Device" (5 trials), "Procedure" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (8 trials), "Aflibercept" (7 trials), "Faricimab" (3 trials), "KSI-301" (3 trials) and "Fluocinolone Acetonide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Foundation; Cole Eye Institute" are 51 trials for "All" genders.

Currently, there are NaN active trials in "Cleveland Clinic Foundation; Cole Eye Institute". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 22 completed trials in Cleveland Clinic Foundation; Cole Eye Institute, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Foundation; Cole Eye Institute, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".